Hot Pursuit     10-Oct-23
Lyka Labs soars after receiving regulatory nod for
Lyka Labs jumped 4.48% to Rs 123.60 after the company announced the receipt of product permission from the Central Drugs Standard Control Organization of India to manufacture and market Tofacitinib Ointment (2% w/w).

The company has received this permission after successfully completing the clinical trial on 125 patients across 8 clinical trial centers within India.

Lyka Labs is one of the pioneers in the field of manufacturing of pharmaceutical formulations & active pharmaceutical ingredients [APIs] across various therapeutic segments.

The company reported a consolidated net loss of Rs 1.85 crore in the quarter ended June 2023 as against net profit of Rs 0.60 crore during the previous quarter ended June 2022. Sales declined 16.77% to Rs 22.88 crore in Q1 FY24 over Q1 FY23.

Previous News
  Lyka Labs reports consolidated net profit of Rs 19.55 crore in the June 2021 quarter
 ( Results - Announcements 04-Aug-21   17:16 )
  Lyka Labs reports consolidated net loss of Rs 1.85 crore in the June 2023 quarter
 ( Results - Announcements 02-Aug-23   14:39 )
  Lyka Labs schedules board meeting
 ( Corporate News - 31-Jul-20   11:03 )
  Lyka Labs to convene AGM
 ( Corporate News - 16-Jul-24   10:33 )
  Lyka Labs to hold EGM
 ( Corporate News - 22-Aug-14   17:20 )
  Lyka Labs reports standalone net loss of Rs 3.06 crore in the December 2020 quarter
 ( Results - Announcements 11-Feb-21   17:29 )
  Lyka Labs reports net loss of Rs 0.92 crore in the March 2008 quarter
 ( Results - Announcements 02-May-08   16:32 )
  Lyka Labs appoints director
 ( Corporate News - 28-Apr-15   19:18 )
  Lyka Labs to convene AGM
 ( Corporate News - 08-Aug-20   12:17 )
  Lyka Labs reports standalone net loss of Rs 2.29 crore in the June 2018 quarter
 ( Results - Announcements 15-Aug-18   14:03 )
  Lyka Labs jumps after pact with Turkish pharma firm
 ( Hot Pursuit - 30-Dec-11   11:52 )
Other Stories
  Nuvama Wealth Mgmt Q1 PAT jumps 79% YoY to Rs 221 cr
  27-Jul-24   16:44
  ICICI Bank Q1 PAT rises 15% YoY to Rs 11,059 cr
  27-Jul-24   15:38
  Punjab & Sind Bank Q1 PAT rises 19% YoY to Rs 181 cr
  27-Jul-24   14:42
  Bandhan Bank Q1 PAT climbs 47% to Rs 1,063 cr
  27-Jul-24   13:31
  BHEL receives LOI for Rs 10,000 crore project from Damodar Valley Corporation
  27-Jul-24   10:54
  Gujarat Themis' Q1 PAT falls over 25% YoY to Rs 13 crore
  27-Jul-24   09:25
  Power Grid Q1 PAT rises 3% YoY to Rs 3,724 cr
  27-Jul-24   08:54
  IndusInd Bank PAT rises to Rs 2,152 cr in Q1 FY25
  26-Jul-24   17:40
  Cipla spurts as Q1 PAT rises 18% YoY to Rs 1,178 cr
  26-Jul-24   15:53
  Shriram Finance soars as Q1 PAT rises 18% YoY
  26-Jul-24   15:33
Back Top